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OBJECTIVE: Refeeding syndrome occurs in patients with severe malnutrition when refeeding begins after a long
period of starvation. This syndrome increases the risk of clinical complications and mortality.
Hypophosphatemia is considered the primary characteristic of the syndrome. The aim of our study was to
investigate the presence of other electrolyte alterations in patients with cancer during the early stage of
refeeding.
METHODS: In this observational study, we enrolled 34 patients with cancer of the upper aerodigestive tract
receiving upfront radiotherapy who were also enrolled in a nutrition program. A caloric intake assessment,
anthropometric measurements and biochemical laboratory tests were performed.
RESULTS: Significant weight loss (,20%) was found in these patients. In the patients receiving artificial
nutrition, we found lower levels of potassium and total protein compared with those who were fed orally
(p=0.03 for potassium and 0.02 for protein, respectively). Patients on enteral tube feeding had a higher caloric
intake compared with those who were fed orally (25¡5 kcal/kg/day vs. 10¡2 kcal/kg/day).
CONCLUSION: Hypokalemia, like hypophosphatemia, could be a complication associated with refeeding in
patients with cancer. Hypokalemia was present in the early stages of high-calorie refeeding.
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& INTRODUCTION
Refeeding syndrome (RS) is a common condition occur-
ring in patients with severe malnutrition (1,2). RS is
associated with an increased risk of clinical complications
and mortality (1,2). The incidence of this condition remains
unknown, given the heterogeneity of the studies on this
issue and the fact that RS is frequently unrecognized. RS is
characterized by electrolyte disorders, such as hypopho-
sphatemia, acute vitamin B1 deficiency, volume overload,
cardiac insufficiency and hyperglycemia.
Furthermore, it has been suggested that potassium and
magnesium may also be altered in RS (3,4). These electrolytes
become depleted during starvation. Successively, during
refeeding, when these electrolytes enter cells, their serum levels
further decline (5,6). Electrolyte disorders develop during the
early phase of refeeding. These conditions could influence the
clinical outcomes of patients because they increase the risk of
complications (7). The aim of this study was to investigate the
eventual presence of hypokalemia during the early phase of
refeeding in patients with cancer. In particular, we investigated
a population of patients affected by tumors of the upper
aerodigestive tract (UADT), which are the most distressing
cancers associated with a long survival period (8).
& METHODS
Between 2009 and 2012, approximately 200 patients with
different types of cancers underwent nutritional status
examinations in the Clinical Nutrition Unit at the
University Magna Grecia of Catanzaro. For this investiga-
tion, only patients having at least one UATD were enrolled.
We included only subjects receiving upfront radiotherapy
(RTx) and who had recently started a nutritional therapy
(at least 1 week before enrollment) orally or as artificial
nutrition. A total of 34 individuals were enrolled. The
study protocol did not require institutional review board
approval because the study was observational. The data
were anonymous; all of the patients provided written
consent to participate in the study, which was performed in
accordance with the principles of the Declaration of
Helsinki.
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Nutritional intake and anthropometric
measurements
All of the tests were performed after a 12-h overnight fast.
The participants’ caloric intake was evaluated with an
interview performed by a dietician during the early days
of refeeding (within 1 week) and was calculated using
MetaDieta nutritional software, version 3.0.1 (Metedasrl, S.
Benedetto del Tronto, Italy). Body weight was measured
before breakfast with the subjects lightly dressed, subtract-
ing the weight of their clothes. Body weight was measured
with a calibrated scale, and height was measured with a
wall-mounted stadiometer. BMI was calculated with the
following equation: weight (kg)/height2 (m2).
Bioelectrical impedance analysis (BIA) (BIA-101;
Akernsrl, Florence, Italy) was performed to estimate total
body water (TBW), fat mass (FM) and total fat-free mass
(FFM) (9).
Handgrip strength was measured using a hydraulic
hand dynamometer (Hersteller/manufactures; SAEHAN
Corporation, Masan, Republic of Korea; Distributor
Rehaforum Medical GmbH, Elmshorn, Germany) with the
subjects seated and their elbows flexed at 90 .˚ The handgrip
strength value was considered to be the maximum amount
of kilograms of force obtained during the test (10).
Skin fold thickness was measured at the triceps with the
GIMA Skinfold Caliper (Gessate, Milan, Italy) (11). The site
was measured three times, and the mean was calculated.
Venous blood was collected into vacutainer tubes (Becton
& Dickinson) and was centrifuged within 4 h. For our
purposes, only abnormalities in serum albumin, total
protein, potassium and sodium were investigated, all of
which were assessed by standard laboratory techniques
(with protein electrophoresis and emission flame photo-
metry for electrolytes) (12).
Statistical analysis
Data are reported as the mean ¡ S.D. We classified the
population into three groups according to the route of
nutrient intake/administration, i.e., oral nutrition (PO),
enteral tube feeding (ETF) or total parenteral nutrition
(TPN). Furthermore, we categorized the participants accord-
ing to cancer type. The t-test and ANOVA were used to
compare the means between groups. Significant differences
were assumed to be present at p,0.05. All of the
comparisons were performed using SPSS software, version
20.0, for Windows (Chicago, IL, USA).
& RESULTS
The mean age of the population was 65¡12years. A total
of 82% of the population was male (n = 28). As expected,
there were significant differences between genders with
respect to handgrip strength (higher in men) and the
number of examinations performed (higher in women)
(p,0.001 and p= 0.038, respectively). Patients on PO had a
mean caloric intake of 10¡2 kcal/kg/day, while patients on
ETF or TPN had a mean caloric intake of 25¡5 kcal/kg/
day.
The patient characteristics are shown in Table 1. In these
patients, weight loss relative to the preceding 3-6 months
was significant (19¡10%).
Figure 1 depicts the types and prevalence of UADT in the
patient population. The figure shows greater weight loss in
patients with pharyngeal and esophageal tumors compared
with the weight loss in patients with other cancer types.
Table 2 shows the significant differences in serum
potassium and total protein levels between patients receiv-
ing different routes of nutrient administration, with the
lowest values found in ETF patients.
& DISCUSSION
In this study, we found lower potassium and total protein
levels during the early phase of refeeding with artificial
nutrition in patients with UADT compared with subjects
who were fed orally (Table 3). In this population, we also
found significant and worrisome weight loss (,20%).
The relationship between cancer and malnutrition is well
established. The percentage of patients with malnutrition is
particularly high for gastrointestinal and head and neck
cancers (13), as confirmed by our study. It is well accepted
that enteral nutrition represents the most favorable nutri-
tional approach because it can reduce hospital stays and
medical complications (14). However, RS can occur as a
result of the reintroduction of nutrients in patients with
severe malnutrition or in starved patients on either ETF or
TPN. Consequently, our study could play an important role
in the recognition, education and prevention of RS. In fact, it
is well known that glucose levels decline with starvation
or under conditions of carbohydrate restriction (15).
Consequently, non-carbohydrate sources (muscle proteins)
are metabolized into glucose. In addition, in the hepato-
cytes, fatty acid oxidation can generate ketone bodies via the
Krebs cycle. Under this condition, there is significant
Table 1 - Characteristics of the study population (total




Weight loss (%) 19.2¡10
Triceps fold (cm) 1¡0.6
Hand grip strength (kg) 24¡10
Serum albumin (g/dl) 3.6¡0.5
Sodium (mEq/l) 136.3¡3
Potassium (mEq/l) 3.9¡0,5




Number of visits 0.83¡1
Figure 1 - UADT prevalence and weight loss.
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depletion of potassium, phosphate and magnesium, as well
as losses of body fat and protein mass. However, a series of
homeostatic mechanisms can maintain the concentrations of
these ions at normal levels (16). During refeeding in great
quantities, when a rapid increase in serum insulin occurs
(15), the movement of extracellular potassium into the
intracellular compartment can result in a dangerous
decrease in potassium levels (15). Symptoms occur when
the changes in serum electrolytes affect the cell membrane
potential. Hypokalemia could be considered an early sign of
RS, and it must be promptly corrected. To reduce the risk of
developing RS, both enteral and parenteral feeding should
be started at a reduced calorie rate (17). In fact, in our
population, different amounts of caloric intake were found
between the groups during the early phase of refeeding
(Table 2). This finding confirms the effects of total energy
administration on the development of hypokalemia and
the risk of RS (17). It is likely that the higher caloric
administration (mean caloric intake of 25¡5 kcal/kg/day)
in the ETF and TPF groups, compared with the PO group,
was the cause of the lower levels of potassium.
The results of this study are important because RS is
frequently unrecognized. Dietitians, nurses and physicians
play important roles in reducing the risk of RS and
improving the quality of life of these particular patients.
This study had some limitations that must be addressed.
First, the results of this study should be interpreted with
caution, as the study was not designed to assess the
mechanisms of RS.
Furthermore, because of the serious clinical conditions of
and limited collaboration obtained from these patients, we
did not perform an accurate nutritional intake investigation
to evaluate micronutrient intake. Finally, another limitation
is the small sample size, although other studies on this topic
used similar sample sizes [18,19].
However, this group of patients could be considered
sufficiently homogeneous because all of the patients were
affected by UADT and did not have significant clinical or
biochemical differences (data not shown).
In conclusion, RS remains a current, unrecognized
problem, and it includes electrolyte disorders, such as
hypokalemia, during the early phase of refeeding. Because
patients with UADT can have longer survival periods than
other patients with cancer, dietitians, nurses and physicians
could improve the quality of life of these particular patients
by considering the complex biochemical manifestations of
RS.
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Table 2 - Characteristics of the population according to
the route of nutrient intake.
PO (48%) ETF (34%) TPN (18%) p-value
Age (years) 67.1¡12 65.3¡10 65.8¡14 ns
BMI 23.1¡6 21¡4 19.4¡3 ns
Weight loss (%) 18.9¡10 18.7¡13 16.2¡6 ns
Albumin (g/dl) 3.8¡0.4 3.4¡0.4 3.7¡0.8 ns
Sodium (mEq/l) 136.8¡2.9 136.5¡4.2 135¡2.4 ns
Potassium (mEq/l) 4.2¡0.5 3.5¡0.5 4.1¡0.2 0.03
Total protein (g/dl) 7.1¡0.5 4.6¡0.1 6.2¡0.3 0.02
TBW (%) 60.3¡10 62.8¡6 63.4¡5 ns
FFM (%) 78.4¡13 79.8¡9 87¡7 ns
FM (%) 21.6¡13 20.1¡9 13¡7 ns
Number of visits 0.46¡0.8 0.8¡1 1¡1 ns
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